| DIRECT COMPETITOR COMPARISON | |
| HSKA | ABAX | BAYRY.PK | IDXX | Industry | | Market Cap: | 35.96M | 511.85M | N/A | 2.96B | 107.08M | | Employees: | 312 | 339 | N/A | 4,800 | 59 | | Qtrly Rev Growth (yoy): | -9.80% | 15.00% | N/A | 11.10% | 19.70% | | Revenue (ttm): | 73.75M | 117.23M | N/A | 1.03B | 13.84M | | Gross Margin (ttm): | 35.48% | 57.99% | N/A | 51.01% | 66.58% | | EBITDA (ttm): | 4.16M | 25.50M | N/A | 225.59M | -12.25M | | Oper Margins (ttm): | 1.71% | 17.34% | N/A | 17.06% | -158.08% | | Net Income (ttm): | -85.00K | 12.97M | N/A | 122.22M | N/A | | EPS (ttm): | -0.002 | 0.577 | N/A | 2.014 | -0.31 | | P/E (ttm): | N/A | 40.26 | N/A | 25.10 | 17.08 | | PEG (5 yr expected): | N/A | 1.6 | 2.21 | 1.25 | 1.15 | | P/S (ttm): | 0.49 | 4.37 | N/A | 2.87 | 9.82 |
|
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 57.21 | 0.00% | 56.92B | 12.69 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 54.09 | 0.00% | 15.64B | 18.10 | | Genzyme Corp. | GENZ | 54.87 | 0.00% | 14.56B | 31.28 | | Merck Serono S.A. | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.30 | 0.00% | 41.66B | 16.41 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 47.82 | 0.00% | 8.54B | 59.92 | | Teva Pharmaceutical Industries Limited | TEVA | 57.10 | 0.00% | 50.31B | 52.24 | | Sandoz International GmbH | Private - View Profile |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Watson Pharmaceuticals Inc. | WPI | 38.10 | 0.00% | 4.04B | 19.64 | | King Pharmaceuticals Inc. | KG | 11.44 | 0.00% | 2.84B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 17.68 | 0.00% | 5.40B | 108.47 | | Pfizer Inc. | PFE | 17.88 | 0.00% | 144.28B | 14.85 | | Johnson & Johnson | JNJ | 62.76 | 0.00% | 173.16B | 14.27 | | GlaxoSmithKline plc | GSK | 38.47 | 0.00% | 97.52B | 12.91 | | Sanofi-Aventis | SNY | 36.29 | 0.00% | 94.76B | N/A | | Novartis AG | NVS | 53.58 | 0.00% | 121.69B | 16.04 | | RHHBY.PK | 41.50 | 0.00% | N/A | N/A |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | AstraZeneca plc | AZN | 44.11 | 0.00% | 64.00B | 8.50 | | Abbott Laboratories | ABT | 53.35 | 0.00% | 82.52B | 14.44 | | Bristol-Myers Squibb Company | BMY | 24.25 | 0.00% | 48.04B | 4.51 |
|
| NEWS ON DIRECT COMPETITORS | |
| • | IDXX | | IDEXX Labs downgraded by Avondale
Mon, Feb 1 -
Briefing.com | | • | IDXX | | New Star Analyst Rankings for IDEXX Laboratories, Inc.
Mon, Feb 1 -
StarMine | | • | ABAX | | Abaxis Misses Zacks Estimate
Mon, Feb 1 -
Zacks.com | | • | ABAX | | New Star Analyst Rankings for ABAXIS, Inc.
Sat, Jan 30 -
StarMine | | • | ABAX | | [$$] Russell 2000 Closes Out January With a Decline of 1%
Fri, Jan 29 -
at The Wall Street Journal Online | | • | IDXX | | UPDATE - Idexx Labs Q4 beats estimates, raises '10 revenue view
Fri, Jan 29 -
at Reuters | | • | IDXX | | Q4 2009 Idexx Laboratories Earnings Release - 07:00 am ET
Fri, Jan 29 -
CCBN | | • | IDXX | | IDEXX LABORATORIES INC /DE Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an
Fri, Jan 29 -
EDGAR Online | | • | ABAX | | ABAXIS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
Thu, Jan 28 -
EDGAR Online | | • | ABAX | | Abaxis Reports Record Revenues for the Third Quarter of Fiscal 2010
Thu, Jan 28 -
PR Newswire | | • | ABAX | | Abaxis to Report Third Quarter Fiscal 2010 Financial Results Thursday, January 28, 2010
Thu, Jan 28 -
PR Newswire | | • | BAYRY.PK | | 10 German Blue-Chips
Wed, Jan 20 -
at Seeking Alpha | | • | BAYRY.PK | | Biotech Stocks: Novo Nordisk, Bayer and J&J lead downward trend
Fri, Jan 15 -
at MarketWatch | | • | BAYRY.PK | | 10 High Yielding German Stocks
Tue, Dec 15 -
at Seeking Alpha | | • | BAYRY.PK | | Bayer Conference Call to discuss new clinical data presented during the Annual Meeting of ASH scheduled for 10:00 am ET today
Tue, Dec 8 -
CCBN | | • | BAYRY.PK | | Biotech Stocks: Europe drug stocks rally; Cephalon slides
Mon, Nov 23 -
at MarketWatch | | • | BAYRY.PK | | UK health unit rejects Bayer drug as too expensive
Thu, Nov 19 -
at MarketWatch | | • | BAYRY.PK | | Trading Outlook for BioElectronics Corporation Issued by StockPreacher.com
Thu, Nov 12 -
GlobeNewswire | | | All Headlines for these symbols... |
|
|
|
1.52% Nasdaq 0.00%
Competitors
